Marken
Healthtech Limited is
a Public company incorporated on 26 March 2024. It is classified as
Non-government company and is registered at Registrar of Companies, Nashik. Its
authorized share capital is Rs. 20,00,00,000 and its paid up capital is Rs. 11,46,23,470
Marken Healthtech Limited operates
in the medical devices and healthcare equipment sector. The company is
primarily involved in the manufacturing, assembling, and/or trading of medical
and diagnostic equipment used in hospitals, clinics, laboratories, and
healthcare centers. Its activities may include dealing in surgical instruments,
diagnostic devices, hospital equipment, patient-care products, and other
health-technology related supplies. The company works in the healthcare
industry by providing medical equipment and related products that support
diagnosis, treatment, and patient care.
Marken Healthtech Limited Share Price, Share Details as
of March 31, 2025
|
Marken Healthtech Outstanding Shares: |
11,462,347 |
|
Face Value of Marken Healthtech Share |
Rs. 10/- Per Equity Share |
|
ISIN of Marken Healthtech Limited Share |
INE0VE701013 |
|
Lot Size of Marken Healthtech Share |
100 |
|
Marken Healthtech Share Price |
Best In Industry |
|
PAN Number of Marken Healthtech |
AARCM9404E |
|
GST Number of Marken Healthtech |
27AARCM9404E1Z7 |
|
Marken Healthtech Limited CIN Number |
U32509MH2024PLC422114 |
|
Marken Healthtech Limited Registration Date |
26 March 2024 |
|
Category / Sub-Category of Marken Healthtech
Limited |
Company limited by
shares/Non-Govt Company |
|
Marken Healthtech Limited Registered Office Address |
Shed No.1,Plot No.93/1, Street No.17, MIDC
Satpur, Satpur Nashik, Satpur Township, Nashik, Nashik, Maharashtra, India,
422007 |
|
Marken Healthtech Limited Registrar & Transfer Agent Address |
Maashitla Securities Private Limited, Plot No 23
24 Gala No 50 In Addi M I D C Area Near Electricity Board Satpur Township
Dindori Nashik 422007 |
|
Directors |
Post |
|
Ritu
Maheshwari |
Independent
Director |
|
Korra
Praveen Naik |
Director |
|
Parameshwara
Chary Chittoju |
Director |
Name and Description of main products/services | NIC Code of the product/service* | % to the total turnover of the Company |
Manufacture of other medical and dental instruments n.e.c. | 32509 |
100% |
Q: What
is the face value of Marken Healthtech Ltd shares?
Answer: The face value of Marken Healthtech Ltd is ₹10 per equity share.
Q: What
is the minimum lot size for buying Marken Healthtech shares through WWIPL?
Answer: The minimum lot size for Marken Healthtech shares is 100 equity
shares.
Q: How
can I buy Marken Healthtech unlisted shares through WWIPL?
Answer: Investors can complete KYC, confirm the transaction details with
WWIPL, transfer funds, and receive shares directly in their Demat account.
Q: Why
should I buy Marken Healthtech shares through WWIPL?
Answer: WWIPL offers transparent pricing, secure transactions, seamless
Demat transfers, and dedicated support throughout the investment process.
Q: Is
investing in Marken Healthtech Ltd a good idea?
Answer: Investors often evaluate Marken Healthtech based on its
healthcare technology solutions, innovation capabilities, financial
performance, and long-term growth prospects.
Q: Why do
investors buy Marken Healthtech shares before a potential IPO?
Answer: Investors seek early exposure to a healthcare technology company
before a potential listing, aiming to participate in future value creation and
liquidity opportunities.
Q: What
business does Marken Healthtech Ltd operate in?
Answer: Marken Healthtech Ltd develops and provides healthcare
technology solutions, including digital healthcare platforms, hospital
management systems, health information technology, and technology-enabled
healthcare services.
Q: What
makes Marken Healthtech different from other unlisted healthtech companies?
Answer: The company focuses on integrating technology with healthcare
delivery, helping hospitals and healthcare providers improve operational
efficiency, patient management, and digital healthcare capabilities.
Q: What
are the key growth drivers for Marken Healthtech Ltd?
Answer: Increasing digitalization of healthcare, adoption of health IT
solutions, hospital technology investments, government digital health
initiatives, and expansion of telehealth services are key growth drivers.
Q: What
factors affect the valuation of Marken Healthtech shares?
Answer: Revenue growth, client acquisition, recurring revenue,
technology innovation, profitability, scalability, and healthcare sector demand
influence the company's valuation.
Q: Are
Marken Healthtech shares available in Demat form?
Answer: Yes. Shares purchased through WWIPL are transferred directly to
the investor's Demat account.
Q: Can I
sell my Marken Healthtech shares through WWIPL?
Answer: Yes. WWIPL facilitates both buying and selling of unlisted
shares, subject to market demand and availability.
Q: What
documents are required to buy Marken Healthtech shares through WWIPL?
Answer: Investors generally need PAN, Aadhaar, Client Master Report
(CMR), and bank account details to complete the transaction.
Q: What
are the risks of investing in Marken Healthtech shares?
Answer: Investors should consider technology disruption, cybersecurity
risks, regulatory changes, competitive pressures, execution risks, and liquidity
constraints associated with unlisted shares.
Q: How
does WWIPL help investors track Marken Healthtech investments?
Answer: WWIPL provides company updates, transaction assistance, market
insights, and investment support to help investors stay informed.
Q: How
long does it take for Marken Healthtech shares purchased through WWIPL to be
credited to the Demat account?
Answer: Shares are generally transferred to the investor's Demat account
after successful completion and verification of the transaction.
Q: What
should investors evaluate before investing in Marken Healthtech Ltd?
Answer: Investors should assess the company's technology platform,
customer base, financial performance, profitability, valuation, scalability,
and long-term growth prospects.
Q: Can
Marken Healthtech benefit from India's digital healthcare transformation?
Answer: Yes. Increasing adoption of digital health solutions, electronic
health records, telemedicine, and government-backed digital healthcare
initiatives may create significant long-term growth opportunities for the
company.